Lineage, Inc. (NASDAQ:LINE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eighteen ...
Q4 2024 Earnings Call Transcript March 10, 2025 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback